Skip to main content
. 2023 Mar 30;41(16):3032–3041. doi: 10.1200/JCO.22.02367

FIG 2.

FIG 2.

Swimmer plot of the treatment duration and best overall response assessed by IRRC as of the data cutoff date for all 78 patients. Arrow indicates ongoing treatment at cutoff date. Two patients were excluded from analysis for reasons that one patient was not confirmed as extranodal natural killer/T-cell lymphoma by central pathology, and the other patient was identified as no measurable or evaluable disease at baseline by IRRC. IRRC, independent radiologic review committee.